ClinicalTrials.gg
Not yet recruitingNCT07823777AppENDUpdated Sep 16, 2026

Appendectomy as an Adjunct Procedure in Endometriosis Surgery

An interventional study of Appendectomy and Standard of Care (SOC) in Endometriosis, sponsored by Mount Sinai Hospital, Canada. Not yet recruiting. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-16.

Sponsored by Mount Sinai Hospital, Canada · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

This study addresses a common but unresolved clinical decision in endometriosis surgery: whether to perform an adjunct appendectomy. Currently, this decision is often based on individual surgeon judgement or institutional practice rather than robust evidence.

This randomized controlled study aims to determine if removing a normal appearing appendix at the time of endometriosis surgery impacts post-operative recurrence of pelvic pain and endometriotic lesions at 12 months. Secondary outcomes include pathology of the appendix and complication rate of the procedure.

Participants will be randomized to appendectomy or no appendectomy at the time of their planned endometriosis surgery. The study also includes an observational cohort that participants may opt to join if they do not wish to be randomized.

Data are expected to guide surgical decision-making and contribute to the development of standardized surgical guidelines.

Read the detailed description

Endometriosis is a chronic inflammatory disease characterized by the growth of endometrial-like tissue outside the uterine cavity, affecting approximately 1 in 10 women and those assigned female at birth during reproductive years. Surgical excision is a cornerstone of endometriosis disease management, particularly in patients with refractory pain, advanced disease, infertility, bowel or urinary tract involvement, or diagnostic uncertainty. However, outcomes are highly variable due to significant variability in surgical approach, underscoring the need for high quality, prospective evidence to optimize surgical intervention.

Appendiceal involvement presents such an opportunity for optimization, which is estimated to impact anywhere from 10-50% of patients in this population. Currently, only appendices that are visually abnormal at the time of surgery are removed. Existing literature, limited to retrospective data, suggests that the addition of appendectomy at the time of endometriosis surgery decreases the risk of postoperative pain and disease recurrence in patients who have received surgical management, regardless of the visual appearance of the appendix.

Notably, visual assessment of the appendix and confirmation of histopathologic appendiceal involvement are not found to be well-correlated.

At this time, there is a lack of quality prospective data to support implementation of adjunct appendectomy into surgical practice. This study aims to bridge this gap by providing the evidence needed to standardize surgical decision-making.

This randomized controlled study will enroll eligible participants between the ages of 18-50 (pre-menopausal), who will undergo laparoscopic or robotic-assisted excision of endometriosis performed by the Minimally Invasive Surgery (MIS) team at Mount Sinai Hospital in Toronto, ON. If the appendix appears normal intraoperatively, the surgeon will proceed with randomized allocation to either appendectomy or no appendectomy. Participants will remain blinded through follow-up, including validated ENDOPAIN-4D questionnaires administered at 6 and 12 months post-operatively and an endometriosis mapping ultrasound at 12 months post-op.

Additional outcomes will assess whether the risk of intra- and post-surgical complications increase with the addition of an appendectomy compared to laparoscopy alone. Data will also be used to evaluate the prevalence of various appendiceal pathologies, including endometriosis- and non-endometriosis-related.

If a participant is unwilling to be randomized but still wishes to participate, they will be invited to join the observational cohort. Participants in this arm will be given the option of whether or not the appendix should be removed during surgery, should it appear normal, aligning with current standard of care. Participants in this arm will undergo all follow-up milestones in an unblinded manner.

The results of this study will be submitted for publication and for presentation at relevant conferences.

02

Conditions studied

  • Endometriosis

Browse trials for

Keywords

  • Appendectomy
03

In context

Endometriosis

920 studies on the registry are indexed under Endometriosis; 266 are open to participants now.

This study's planned enrollment of 240 is above the median of 67 across 540 interventional studies indexed under Endometriosis.

Browse Endometriosis studies →

Lead sponsor

Mount Sinai Hospital, Canada is the lead sponsor of 158 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-50 years
  • Endometriosis diagnosis based on imaging or prior surgical findings
  • Baseline pain above 3 on the Numerical Rating Scale (NRS)
  • Undergoing surgical excision of endometriosis only, with at least one remaining ovary

Exclusion criteria

Exclusion criteria:

  • Abnormal appearing appendix on imaging or intraoperatively
  • No endometriosis seen at the time of surgery
  • Previous appendectomy
  • Menopausal
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Appendectomy

    Participants randomized to have their appendix removed

    Procedure: Appendectomy

  • Active comparator
    No appendectomy

    Participants randomized to not have their appendix removed

    Procedure: Standard of Care (SOC)

  • No intervention
    Observational Cohort

    Participants will choose whether or not to have their appendix removed during surgery if it appears normal

Interventions

  • ProcedureAppendectomy

    Removal of the appendix at the time of endometriosis surgery

  • ProcedureStandard of Care (SOC)

    If the appendix appears normal during surgery it will not be removed

06

What researchers measure

Primary outcomes

  1. Change in pelvic pain severity

    Change from baseline to 1 year in post-operative pain severity as measured by the ENDOPAIN-4D questionnaire (lower score = less pain)

    Time frame: 1 year

  2. Rate of endometriosis lesion recurrence

    Rates of recurrence of endometriosis lesions based on 12-month endometriosis mapping ultrasound

    Time frame: 1 year

Secondary outcomes

  1. Change in pelvic pain severity

    Change from baseline to 6 months in post-operative pain severity as measured by the ENDOPAIN-4D questionnaire (lower score = less pain)

    Time frame: 6 months

  2. Change in pelvic pain severity

    Change from baseline to 6 months in post-operative pain severity as measured by the Numerical Rating Scale (NRS; lower score = less pain)

    Time frame: 6 months

  3. Change in pelvic pain severity

    Change from baseline to 1 year in post-operative pain severity as measured by the Numerical Rating Scale (NRS; lower score = less pain)

    Time frame: 1 year

  4. Postoperative complications

    Postoperative analgesia use, sleep disturbances, and lifestyle impact at 30 days, reported by participant

    Time frame: 30 days

  5. Rate of positive appendiceal pathology

    Pathology findings from appendix analysis

    Time frame: 30 days

  6. Types of appendiceal pathology

    Types of endometriosis and non-endometriosis appendiceal pathology identified via histopathological analysis of removed appendices

    Time frame: 30 days

  7. Operative time

    Duration of surgery

    Time frame: During surgery

  8. Postoperative analgesia use

    Frequency of analgesic use post-surgery to manage pain

    Time frame: 1 year

  9. Percentage of eligible participants willing to be randomized

    Of those who met study criteria, what percentage were willing to be randomized

    Time frame: 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07823777
Responsible party
Olga Bougie (MD, MPH, FRCSC. Associate Professor, Mount Sinai Hospital, Canada) — Principal investigator
First posted
Sep 16, 2026
Start date
Apr 2027 (estimated)
Primary completion
Apr 2028 (estimated)
Completion
Apr 2029 (estimated)
Last update
Sep 16, 2026

Study contacts

Research Coordinator
Contact
tbd@sinaihealth.ca
416-586-8800 ext. 5526
Olga Bougie, MD
principal investigator · MOUNT SINAI HOSPITAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion